New Issue: ABN Amro prices $0.387 million 14.25% reverse convertibles linked to Merck

New York, April 29 - ABN Amro Bank NV priced $0.387 million of 14.25% Knock-In Reverse Exchangeable notes due July 31, 2009 linked to Merck & Co., Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.

Payout at maturity will be par in cash unless Merck shares fall below the protection price of $17.58, 75% of the initial price of $23.44, during the life of the notes and finish below the initial price in which case the payout will be 42.662 shares of Merck stock.

ABN Amro Inc. is the agent.

Issuer:	ABN Amro Bank NV
Issue:	Knock-In Reverse Exchangeable notes
Underlying stock:	Merck & Co., Inc. (Symbol: MRK)
Amount:	$0.387 million
Maturity:	July 31, 2009
Coupon:	14.25%, payable monthly
Price:	Par
Payout at maturity:	Par in cash unless Merck shares fall below the protection price of $17.58, 75% of the initial price, and finish below the initial price, in which case 42.662 shares of Merck stock
Initial price:	$23.44
Protection price:	$17.58, 75% of $23.44
Exchange ratio:	42.662
Pricing date:	April 27
Settlement date:	April 30
Agent:	ABN Amro Inc.
Fees:	1.375%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.